Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 06 Mar 2023
USA: The syrup drug Diethylene glycol (DEG), a drug commonly used to prevent infections, is the cause of kidney disease...
Read Full NewsNon-Factor Therapies in Hemophilia: Cutting-Edge Approaches to Individualize Care
Precision Medicine in mHSPC: Integrating Novel Biomarkers, Imaging, and Emerging Targeted Agents
Accelerating the Evidence-Based Integration of Menin Inhibitors Into R/R AML Care: A Live Expert TheraTalk
Frontline Decisions in Transplant-Ineligible Multiple Myeloma: Evaluating Quadruplet Therapy
1.
high response rate when using a bispecific antibody to treat R/R multiple myeloma.
2.
Anti-PD-L1 Plus Targeted Agent No Better Than Chemo for Resistant NSCLC
3.
Child Death Rates Are Rising in the U. s. ; Water Beads Warning; Cancer Studies Retracted.
4.
Liquid Biopsy for Colorectal Cancer Screening Might Not Be Ready for Prime Time.
5.
iPSC-based vaccines: A new hope for preventing and treating colorectal cancer
1.
How EPCORITAMAB is Revolutionizing the Treatment of Cancer
2.
Unlocking the Mystery of Granulomas: A Closer Look at the Causes and Treatment
3.
New Frontiers in Diagnosing and Managing Myelodysplastic Syndromes (MASLD)
4.
Hypercoagulable State: Factors that Contribute to Blood Clots
5.
Understanding Epidural Hematoma: Symptoms, Causes and Treatment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VIII
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
3.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part IV
4.
Rates of CR/CRi and MRD Negativity in Iontuzumab-Treated Patients
5.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge